Pacific Biosciences of California Aktie
WKN DE: A1C3EQ / ISIN: US69404D1081
27.03.2025 14:53:59
|
PacBio Appoints Jim Gibson As New CFO
(RTTNews) - Life science technology company PacBio, Inc. (PACB) announced Thursday the appointment of Jim Gibson as the company's new Chief Financial Officer, effective as of his start date, which is expected to be March 31, 2025.
With over three decades of financial leadership experience at some of Silicon Valley's most iconic and innovative companies, Gibson brings a deep track record of operational excellence, strategic financing, and scaling global organizations.
Gibson joins PacBio from Sequoia, a strategic compensation and benefits solutions provider, where he served as CFO across four entities. Prior to Sequoia, Gibson was CFO at Willow Innovations.
Additionally, he has held executive roles at GoDaddy, Tesla, Apple, Netflix, and Affymetrix, where he helped scale businesses, integrate acquisitions, and deliver over $1B in raised capital across his career.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pacific Biosciences of California Incmehr Nachrichten
06.08.25 |
Ausblick: Pacific Biosciences of California stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
23.07.25 |
Erste Schätzungen: Pacific Biosciences of California stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
07.05.25 |
Ausblick: Pacific Biosciences of California legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
23.04.25 |
Erste Schätzungen: Pacific Biosciences of California gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) |
Analysen zu Pacific Biosciences of California Incmehr Analysen
Aktien in diesem Artikel
Pacific Biosciences of California Inc | 1,09 | 0,07% |
|